125 related articles for article (PubMed ID: 18318437)
1. Mortality attributable to cholestatic liver disease in the United States.
Mendes FD; Kim WR; Pedersen R; Therneau T; Lindor KD
Hepatology; 2008 Apr; 47(4):1241-7. PubMed ID: 18318437
[TBL] [Abstract][Full Text] [Related]
2. Transplantation trends in primary biliary cirrhosis.
Lee J; Belanger A; Doucette JT; Stanca C; Friedman S; Bach N
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1313-5. PubMed ID: 17900996
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation in PBC and PSC: indications and disease recurrence.
Carbone M; Neuberger J
Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):446-54. PubMed ID: 21459072
[TBL] [Abstract][Full Text] [Related]
4. Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New Zealand.
Ngu JH; Gearry RB; Frampton CM; Stedman CA
Hepatology; 2012 Feb; 55(2):522-9. PubMed ID: 21994151
[TBL] [Abstract][Full Text] [Related]
5. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.
Webb GJ; Rana A; Hodson J; Akhtar MZ; Ferguson JW; Neuberger JM; Vierling JM; Hirschfield GM
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):278-287.e7. PubMed ID: 28993258
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.
Maheshwari A; Yoo HY; Thuluvath PJ
Am J Gastroenterol; 2004 Mar; 99(3):538-42. PubMed ID: 15056099
[TBL] [Abstract][Full Text] [Related]
7. Waitlist mortality and post-transplant survival in patients with cholestatic liver disease - Impact of changes in allocation policy.
Staufer K; Kivaranovic D; Rasoul-Rockenschaub S; Soliman T; Trauner M; Berlakovich G
HPB (Oxford); 2018 Oct; 20(10):916-924. PubMed ID: 29937419
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Loehe F; Schauer RJ
Clin Rev Allergy Immunol; 2005 Apr; 28(2):167-74. PubMed ID: 15879622
[TBL] [Abstract][Full Text] [Related]
9. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
Faust TW
Semin Liver Dis; 2000; 20(4):481-95. PubMed ID: 11200417
[TBL] [Abstract][Full Text] [Related]
10. Male Sex Is Associated With Higher Rates of Liver-Related Mortality in Primary Biliary Cholangitis and Cirrhosis.
John BV; Aitcheson G; Schwartz KB; Khakoo NS; Dahman B; Deng Y; Goldberg D; Martin P; Taddei TH; Levy C; Kaplan DE
Hepatology; 2021 Aug; 74(2):879-891. PubMed ID: 33636012
[TBL] [Abstract][Full Text] [Related]
11. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis.
Wiesner RH; Porayko MK; Dickson ER; Gores GJ; LaRusso NF; Hay JE; Wahlstrom HE; Krom RA
Hepatology; 1992 Nov; 16(5):1290-9. PubMed ID: 1427667
[TBL] [Abstract][Full Text] [Related]
12. Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation.
Singal AK; Fang X; Kaif M; Hasanin M; Mcguire BM; Kuo YF; Wiesner RH
Transpl Int; 2017 May; 30(5):454-462. PubMed ID: 27754570
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models.
Wiesner RH
Mayo Clin Proc; 1998 Jun; 73(6):575-88. PubMed ID: 9621867
[TBL] [Abstract][Full Text] [Related]
14. Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment.
Lu M; Zhou Y; Haller IV; Romanelli RJ; VanWormer JJ; Rodriguez CV; Anderson H; Boscarino JA; Schmidt MA; Daida YG; Sahota A; Vincent J; Bowlus CL; Lindor K; Zhang T; Trudeau S; Li J; Rupp LB; Gordon SC;
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1342-1350.e1. PubMed ID: 29277621
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
[TBL] [Abstract][Full Text] [Related]
16. Overlap syndromes.
Beuers U; Rust C
Semin Liver Dis; 2005 Aug; 25(3):311-20. PubMed ID: 16143946
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome.
Strasser S; Sheil AG; Gallagher ND; Waugh R; McCaughan GW
J Gastroenterol Hepatol; 1993; 8(3):238-43. PubMed ID: 8518394
[TBL] [Abstract][Full Text] [Related]
18. Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups.
Longworth L; Young T; Buxton MJ; Ratcliffe J; Neuberger J; Burroughs A; Bryan S;
Liver Transpl; 2003 Dec; 9(12):1295-307. PubMed ID: 14625830
[TBL] [Abstract][Full Text] [Related]
19. Primary biliary cirrhosis (PBC) in an European country--a description of death rates in The Netherlands (1979-1992).
van Dam GM; Gips CH
Hepatogastroenterology; 1996; 43(10):906-13. PubMed ID: 8884312
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Hay JE
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]